Max Wallace
Vermögen: 50 353 $ am 30.06.2026
Vermögen: 50 353 $ am 30.06.2026
Max Wallace is the founder of Trimeris, Inc., founded in 1993, where the title held was President from 1993 to 1997.
Mr. Wallace is the founder of Cogent Neuroscience, Inc., founded in 1998, with no titles listed.
Mr. Wallace is also the founder of Sphinx Pharmaceuticals Corp,Sarco, Inc.,DUMAC, Inc.,NC Life Sciences Organization..
Mr. Wallace is an Independent Director at Humacyte, Inc. since 2021.
Mr. Wallace is President of RoundTable Research LLC since 2023.
Mr. Wallace was Chief Executive Officer at Accelerate Brain Cancer Cure, Inc. from 2008 to 2019.
Mr. Wallace was Chief Executive Officer at TheraLogics, Inc. from 2004 to 2008.
Mr. Wallace was Director at Biotechnology Innovation Organization.
Mr. Wallace was Director-Government Relations at Duke University from 1987 to 1990.
Mr. Wallace was Director at Humacyte Global, Inc. from 2005 to 2021.
Mr. Wallace was President at Cogent.
Mr. Wallace was Legal Counsel at Duke University Medical Center.
Mr. Wallace completed undergraduate education at Duke University.
Mr. Wallace completed graduate education at the University of Florida.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
HUMACYTE, INC. 0,02 % | 11.06.2026 | 64.555 ( 0,02 % ) | 50 353 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| HUMACYTE, INC. | Direktor/Vorstandsmitglied | 26.08.2021 |
RoundTable Research LLC
RoundTable Research LLC Miscellaneous Commercial ServicesCommercial Services Provides noncommercial research organizations and management consulting services | Präsident | 01.03.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
Humacyte Global, Inc.
Humacyte Global, Inc. Medical SpecialtiesHealth Technology Develops human tissue-based investigational products | Direktor/Vorstandsmitglied | 01.08.2021 |
Accelerate Brain Cancer Cure, Inc.
Accelerate Brain Cancer Cure, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization, which focuses on speeding the discovery of a cure for brain cancer | Vorstandsvorsitzender | 01.12.2019 |
TheraLogics, Inc. | Vorstandsvorsitzender | 01.01.2008 |
Cogent Neuroscience, Inc. | Gründer | 01.01.2002 |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for viral diseases | Gründer | 01.01.1997 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 16 |
|---|---|
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for viral diseases | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Humacyte Global, Inc.
Humacyte Global, Inc. Medical SpecialtiesHealth Technology Develops human tissue-based investigational products | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sphinx Pharmaceuticals Corp
Sphinx Pharmaceuticals Corp Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Sarco, Inc.
Sarco, Inc. Miscellaneous Commercial ServicesCommercial Services Provides chemical libraries for potential use in biopharmaceutical industry | Commercial Services |
Cogent
Cogent Information Technology ServicesTechnology Services Develops integrated office solutions such as software, maintenance services, and cost systems | Technology Services |
University of Florida
University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DUMAC, Inc.
DUMAC, Inc. Investment ManagersFinance DUMAC seeks to achieve an annualized real rate of return to fund the University’s spending and to allow for growth of the endowment after considering the effects of inflation. The firm measures actual allocation of investment exposures against target allocations articulated in their investment policy. | Finance |
Duke University Medical Center
Duke University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NC Life Sciences Organization
NC Life Sciences Organization Miscellaneous Commercial ServicesCommercial Services Focuses primarily on legislative monitoring and lobbying activities at the state and federal level | Commercial Services |
Accelerate Brain Cancer Cure, Inc.
Accelerate Brain Cancer Cure, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization, which focuses on speeding the discovery of a cure for brain cancer | Commercial Services |
Cogent Neuroscience, Inc. | |
Humacyte, Inc.
Humacyte, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
TheraLogics, Inc. | |
RoundTable Research LLC
RoundTable Research LLC Miscellaneous Commercial ServicesCommercial Services Provides noncommercial research organizations and management consulting services | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen